2nd Quarter - Report

AKIN GUMP STRAUSS HAUER & FELD for EUROAPI

Period 2nd Quarter 2023 Filed Jul 20, 2023 Signed by Brian Pomper

Official filing
Firm
AKIN GUMP STRAUSS HAUER & FELD
Client
EUROAPI
Income
$80,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to onshoring biopharmaceutical manufacturing.

LobbyistCovered position, as disclosed
HEIDE BAJNRAUH —
DANIEL GRAVER —
MARIO RAMIREZ —

Contacted: Office of Science & Technology Policy (OSTP); SENATE; Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES

Manufacturing MAN

Issues related to onshoring biopharmaceutical manufacturing.

LobbyistCovered position, as disclosed
DANIEL GRAVER —

Contacted: Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Pharmacy PHA

Issues related to onshoring biopharmaceutical manufacturing.

LobbyistCovered position, as disclosed
DANIEL GRAVER —

Contacted: HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.